Common use
Memantine (brand name Namenda) is an NMDA receptor antagonist prescribed for the treatment of moderate to severe Alzheimer's disease and other forms of dementia. It works by regulating the activity of glutamate, one of the brain's most important excitatory neurotransmitters. In Alzheimer's disease, excessive glutamate stimulation can lead to excitotoxicity — a process that damages and destroys neurons. Memantine blocks this abnormal glutamate signaling by selectively binding to NMDA receptors, protecting brain cells from excitotoxic damage while still allowing normal neural communication necessary for learning and memory. By stabilizing cognitive function and slowing the progression of symptoms, memantine helps patients maintain their ability to perform daily activities, communicate, and interact with caregivers for a longer period. If you are looking to buy memantine online, dutypills.ovh offers this essential Alzheimer's medication at affordable prices with reliable delivery.

Dosage and direction
Memantine is available as immediate-release tablets (taken twice daily) and extended-release capsules (taken once daily), as well as an oral solution. Your healthcare provider will determine the most appropriate formulation and dosage for your needs. Treatment typically begins with a low dose (5 mg once daily for immediate-release) that is gradually increased over several weeks to minimize side effects and allow the body to adjust. The target maintenance dose is usually 10 mg twice daily for immediate-release tablets or 28 mg once daily for extended-release capsules. Memantine may be taken with or without food, but it should be taken consistently the same way each day. Follow your healthcare provider's dosing instructions carefully and do not change the dose without medical consultation.

Precautions
Before starting memantine therapy, inform your doctor if you have kidney disease or impaired renal function, as dose adjustments may be necessary since the drug is primarily excreted through the kidneys. Also discuss any history of heart conditions, seizure disorders, high blood pressure, urinary tract obstruction or infection, or conditions that alter urine pH (such as renal tubular acidosis or severe urinary tract infections). Memantine may cause dizziness, headaches, confusion, or drowsiness, particularly during the initial dose-titration period, so exercise caution when driving, operating machinery, or engaging in activities that require alertness. Adequate hydration is important during treatment. Caregivers should monitor patients for any sudden changes in behavior, mood, or cognitive status.

Contraindications
Memantine is contraindicated in individuals with known hypersensitivity to memantine hydrochloride or any inactive ingredients in the formulation. Patients who have experienced severe allergic reactions to this medication or structurally similar compounds should avoid use. There are no absolute organ-specific contraindications, but severe renal impairment requires significant dose reduction, and use should be carefully evaluated by a physician in such cases.

Possible side effect
Common side effects of memantine include dizziness, headache, constipation, confusion, drowsiness, and sleep disturbances (insomnia or excessive sleepiness). Some patients may also experience hypertension, back pain, or flu-like symptoms. More serious side effects that require prompt medical attention include severe allergic reactions (rash, hives, swelling of the face, lips, or tongue, difficulty breathing), sudden or significant changes in mood or behavior, hallucinations, visual disturbances, heart rhythm abnormalities (irregular or rapid heartbeat), seizures, and difficulty urinating. If any of these serious symptoms occur, discontinue use and seek immediate medical care.

Drug interaction
Memantine may interact with other NMDA receptor antagonists such as amantadine, ketamine, and dextromethorphan, potentially increasing the risk of adverse effects. Medications that alter urine pH, including carbonic anhydrase inhibitors (acetazolamide) and sodium bicarbonate, can affect memantine clearance and may require dose adjustments. Certain blood pressure medications, diuretics (particularly hydrochlorothiazide), and drugs that affect kidney function may also interact with memantine. Cimetidine, ranitidine, procainamide, quinidine, quinine, and nicotine may affect memantine excretion. Always provide your doctor with a complete list of all prescription medications, over-the-counter products, vitamins, and supplements you are taking.

Missed dose
If a dose of memantine is missed, take it as soon as you remember unless it is almost time for the next scheduled dose. In that case, skip the missed dose and continue with the regular dosing schedule. Do not take two doses at once or extra medication to compensate for a missed dose. If several doses are missed in a row, contact your healthcare provider before resuming, as gradual re-titration may be needed to reduce the risk of side effects.

Overdose
Symptoms of memantine overdose may include severe dizziness, restlessness, agitation, nausea, vomiting, confusion, hallucinations, drowsiness, stupor, loss of consciousness, and rarely cardiovascular instability. If an overdose is suspected, seek immediate emergency medical attention. Treatment is primarily supportive, as there is no specific antidote for memantine. Elimination may be enhanced by acidification of urine, but this approach requires careful medical supervision.

Storage
Store memantine tablets and capsules at room temperature between 15-30°C (59-86°F), away from heat, moisture, and direct light. Keep the medication in its original container, tightly closed, and out of reach of children and pets. Oral solution should be stored according to the specific instructions on the label. Do not use memantine after the expiration date.

Disclaimer

We provide only general information about medications which does not cover all directions, possible drug integrations, or precautions. Information at the site cannot be used for self-treatment and self-diagnosis. Any specific instructions for a particular patient should be agreed with your health care adviser or doctor in charge of the case. We disclaim reliability of this information and mistakes it could contain. We are not responsible for any direct, indirect, special or other indirect damage as a result of any use of the information on this site and also for consequences of self-treatment.